Intel CEO Pat Gelsinger has expressed disappointment over the delayed allocation of funds under the US government's Chip and Science Act. According to a report by The New York Times, Gelsinger and US Commerce Secretary Gina Raimondo recently discussed the issue in an interview. The Chip and Science Act, signed into law in August 2022, aims to promote US chip manufacturing and reduce dependence on foreign suppliers. However, the allocation of funds to support the act has been delayed, causing concern among industry leaders like Gelsinger. In a recent statement, Gelsinger emphasized the importance of timely funding for the chip industry, citing the need for investment in research and development to stay competitive. The delayed allocation of funds may impact Intel's plans to expand its chip manufacturing capabilities in the US. The company had hoped to use the funds to establish a new chip factory in Arizona, creating thousands of new jobs. Despite the delay, Gelsinger remains optimistic about the potential of the Chip and Science Act to boost the US chip industry, but he emphasized the need for swift action to avoid a further decline in the industry.